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Stem cell factor (SCF) delays differentiation and enhances the expansion of erythroid progenitors. Previ-
ously, we performed expression-profiling experiments to link signaling pathways to target genes using poly-
some-bound mRNA. SCF-induced phosphoinositide-3-kinase (PI3K) appeared to control polysome recruit-
ment of specific mRNAs associated with neoplastic transformation. To evaluate the role of mRNA translation
in the regulation of expansion versus differentiation of erythroid progenitors, we examined the function of the
eukaryote initiation factor 4E (eIF4E) in these cells. SCF induced a rapid and complete phosphorylation of
eIF4E-binding protein (4E-BP). Overexpression of eIF4E did not induce factor-independent growth but
specifically impaired differentiation into mature erythrocytes. Overexpression of eIF4E rendered polysome
recruitment of mRNAs with structured 5 untranslated regions largely independent of growth factor and
resistant to the PI3K inhibitor LY294002. In addition, overexpression of eIF4E rendered progenitors insen-
sitive to the differentiation-inducing effect of LY294002, indicating that control of mRNA translation is a major
pathway downstream of PI3K in the regulation of progenitor expansion.
Leukemia may arise through mechanisms that enable the
proliferation and survival of normal cells when expansion of
the progenitor pool is required. The control of the balance
between expansion and maturation by cytokines and growth
factors is such a mechanism. While erythroid progenitors re-
quire erythropoietin (Epo) to mature into erythrocytes, the
progenitor pool can be expanded both in vivo and in vitro in
response to the cooperative action of Epo, stem cell factor
(SCF), and glucocorticoids (6, 9, 16, 49). SCF cooperates with
Epo to suppress differentiation and sustain renewal divisions of
erythroid progenitors. Cooperation of SCF and cytokines has
also been observed in other hematopoietic progenitors (10). A
mutated SCF receptor (v-Kit) was initially identified as a viral
oncogene in a feline leukemia virus (40). Mutations in c-Kit
that induce constitutive activity are found specifically in t(8;21)
and inv (16) leukemia, but autocrine loops activating c-Kit are
also reported in other types of leukemia (7, 51). In an avian
model system, SCF cooperates with oncogenic MLL fusion
genes to transform lymphomyeloid multipotent progenitors
(42). Furthermore, activating c-Kit mutations are common in
gastrointestinal stromal tumors (29) and in bilateral testicular
germ cell tumors (33). This suggests that the inhibition of
erythroid differentiation by SCF may exemplify a more general
role of SCF in the regulation of cell growth and differentiation.
The expansion of erythroid progenitors in the presence of
SCF is abrogated by the phosphatidylinositol 3 kinase (PI3K)
inhibitor LY294002 (49), resulting in terminal differentiation
instead. An important effector of PI3K is protein kinase B
(PKB), which controls cellular processes such as cell cycle
progression, apoptosis, and mRNA translation through the
phosphorylation of, e.g., Forkhead transcription factors, the
proapoptotic protein Bad, and the mammalian target of rapa-
mycin (mTOR) (1, 5, 13, 19, 25, 39). To identify critical path-
ways and targets downstream of SCF signaling, we performed
profiling experiments using polysome-bound mRNA to detect
those mRNAs that are expressed and translated into protein.
The expression of the putative oncogene Ndpk-B (nucleoside
diphosphate kinase B) (also known as Nm23-M2 or Nme2)
appeared to be regulated by SCF. Regulation did not occur at
the level of gene transcription but exclusively through the re-
cruitment of its mRNA into polysomes, which was fully depen-
dent on PI3K activity (28). As selective recruitment of mRNAs
into polysomes appears to be an important regulatory mecha-
nism in cell growth control and tumorigenesis (4, 41), we ex-
amined the role of mRNA translation in PI3K-dependent
control of the expansion and differentiation of erythroid pro-
genitors.
The mRNA cap-binding eukaryote initiation factor 4E
(eIF4E) recruits the scaffolding protein eIF4G, which associ-
ates with, among others, the mRNA helicase eIF4A and the
small subunit of the ribosome. This complex scans the 5 un-
translated region (5UTR) of mRNA until an appropriate
AUG codon is recognized. In binding to the limiting factor
eIF4E, eIF4G has to compete with 4E-binding proteins (4E-
BP). Unphosphorylated 4E-BP binds and inhibits eIF4E, but
eIF4E is released upon the phosphorylation of 4E-BP by the
mTOR kinase (23). The increased availability of eIF4E is as-
sociated with cell proliferation (19). Increased levels of eIF4E
are detected in a number of solid tumors, especially in breast,
colon, and head/neck tumors (15). Interference with transla-
tion initiation via the overexpression of an mTOR-insensitive
4E-BP1 results in the inhibition of the cell cycle progression
(19). These observations suggest that the availability of eIF4E
in translation initiation contributes to neoplastic transforma-
tion. In addition, it has also been suggested that eIF4E en-
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hances nucleocytoplasmic transport of specific transcripts. The
aberrant regulation of eIF4E-dependent mRNA transport
contributed to leukemogenesis, as it impaired granulocytic and
monocytic differentiation (46).
Although eIF4E and its associated factors are general trans-
lation factors, they bind and scan mRNAs with a short and
simple 5UTR much more efficiently than mRNAs with a long
and structured 5UTR. The 5UTR of the nm23-M2 transcript,
which is strictly dependent on Epo- and SCF-induced PI3K
activity, begins with a terminal oligopyrimidine (TOP) se-
quence and contains an inverted repeat (28). The TOP se-
quence confers selective translation to a given mRNA as poly-
some recruitment becomes dependent on mTOR activation
(27). TOP sequences are present in mRNAs encoding ribo-
somal proteins and elongation factors to render the energy-
consuming process of ribosome biogenesis dependent on the
presence of mitogenic factors and nutrients. Additional sec-
ondary structures within the 5UTR may also control mRNA
translation, such as the iron response element that renders
translation of the transferrin receptor dependent on the avail-
ability of iron (45).
In this paper, we show that control of mRNA translation is
an important PI3K-dependent pathway regulating progenitor
expansion. We demonstrate that SCF induces rapid PI3K-
dependent phosphorylation of 4E-BP and that overexpression
of eIF4E in erythroid progenitors delays differentiation and
enhances renewal divisions in the absence of SCF. We identi-
fied mRNAs upregulated by SCF-induced polysome recruit-
ment. These mRNAs contain a long and structured 5UTR
(Y-box-binding protein 1), a short 5UTR starting with a TOP
sequence (the splicing factor U2-Snrpb), or both a TOP se-
quence and an inverted repeat (Nm23-M2). Polysome recruit-
ment of all three mRNAs was strongly enhanced by eIF4E
overexpression in cells that were factor deprived, while eIF4E
overexpression did not affect polysome association in the pres-
ence of SCF.
MATERIALS AND METHODS
Cells. I/11 cells were cultivated in StemPro-34 medium (Life Technologies) as
described previously (49). For expansion, the medium was supplemented with 0.5
U/ml Epo (kind gift from Ortho-Biotech, Tilburg, The Netherlands), 100 ng/ml
SCF (supernatant of CHO producer cells), and 106M dexamethasone (Dex;
Sigma-Aldrich). To induce differentiation, cells were cultivated in StemPro-34
medium supplemented with 5 U/ml Epo and 0.5 mg/ml iron-loaded transferrin
(Intergene). Cell numbers and cell size distribution were determined using an
electronic cell counter (CASY-1; Scha¨rfe-System, Reutlingen, Germany).
LY294002 and rapamycin were obtained from Alexis (Switzerland).
Hemoglobin content determination and cell morphology. Small aliquots of the
cultures were removed and analyzed for hemoglobin content by photometry as
described earlier (5, 31). The values obtained were the averages of triplicate
measurements after normalization for cell number and mean single cell volume.
Cell morphology was analyzed in cytospins stained with histological dyes and
neutral benzidine (8) using an Olympus BX40 microscope (40 lens objective;
numerical aperture, 0.65), an Olympus DP50 charge-coupled-device camera, and
Viewfinder Lite 1.0 acquisition software. Images were cropped using Adobe
Photoshop 6.0.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE),
Western blotting, immunoprecipitation, and antibodies. For acute stimulation
with growth factors, proliferating I/11 cells were washed twice with phosphate-
buffered saline (PBS) and seeded at 4  106 cells/ml in plain Iscove’s modified
Dulbecco’s medium (Life Technologies). After 4 h of factor deprivation, cells
were stimulated at 37°C with SCF (100 ng/ml) or Epo (5 U/ml). Cells were
harvested after the indicated time points by the addition of ice-cold PBS. Cell
lysates, SDS-PAGE, immunoprecipitation, and Western blotting were per-
formed as described previously (48). To analyze eIF4E and 4E-BP, 10 l of
protein extract (1  106 cells) was loaded onto a 15% polyacrylamide gel. The
antibodies used were the following: anti-eIF4E, anti-4E-BP1, anti-phospho-4E-
BP1(Thr37/46), anti-phospho-4E-BP1(Ser65) (Cell Signaling Technology, Inc.),
anti-ERK1(K-23), and anti-Myc (gE10, Santa Cruz Biotechnology, Inc.). For
immunoprecipitation, Myc-eIF4E was immunoprecipitated from the lysate of 15
 106 cells by an overnight incubation at 4°C with monoclonal anti-Myc anti-
bodies (1 g antibody/15  106 cells), followed by an hour of incubation at 4°C
with 15 l of a 50% solution of protein G-Sepharose beads (Pharmacia LKB).
m7GTP-Sepharose affinity chromatography. For the isolation of eIF4E and
associated proteins, 15  106 cells were lysed in buffer C (50 mM MOPS
[morpholinepropanesulfonic acid]-KOH [potassium hydroxide] [pH 7.2], 0.5 mM
EDTA, 0.5 mM EGTA, 100 mM KCl, 14 mM 2-mercaptoethanol, 50 mM NaF,
100 M GTP, and protease inhibitor cocktail) and subjected to m7GTP-Sepha-
rose chromatography as described previously (35). Briefly, the lysed cells were
incubated at 4°C with 25 l of equilibrated Sepharose resin (7-methyl GTP-
Sepharose 4B; Amersham Biosciences) for 1 h. The resin was washed three times
with buffer C, and recovered proteins were eluted directly into sample buffer for
SDS-PAGE analysis.
Generation of myc-eIF4E-expressing I/11 clones. The myc-eIF4E cDNA
(NCBI accession number M61731) containing six myc tags at the 5 start of the
coding sequence was isolated from the pCS3MT vector and inserted into the
eukaryotic retroviral expression vector pBabe using EcoRI and BamHI restric-
tion sites. Retroviral transduction was performed as described previously (5).
Briefly, 0.5  106 ecotropic Phoenix cells were transfected with 12 g plasmid
DNA (myc-eIF4E-pBabe) using a calcium-phosphate coprecipitation assay. Af-
ter 40 h, cells were treated with 10 g/ml mitomycin C (Kyowa Hakko Kogyo,
Tokyo, Japan) for 1 h and washed three times with PBS. A total of 2  106 I/11
cells was added in 4 ml StemPro-34 medium supplemented with Epo, SCF, and
Dex and cocultured for 24 h. Subsequently, I/11 cells were removed from the
Phoenix cells and cultured in semisolid medium (methocel-containing StemPro-
34, supplemented with factors) containing 2 g/ml puromycin (Sigma). After 7
days, well-separated colonies were picked, expanded, and analyzed for myc-
eIF4E expression.
Immunofluorescence microscopy. Cells (eIF4E-overexpressing and empty vec-
tor clones) were spun onto a microscope slide. The cells were fixed in 4%
paraformaldehyde and permeabilized for 30 min with 0.2% Triton X-100. After
being blocked for 1 h in PBS containing 1% bovine serum albumin and 0.05%
Tween 20, the fixed cells were incubated for 1 h at room temperature with
anti-eIF4E antibody and with anti-Myc antibodies for the eIF4E-overexpressing
cells. The slides were washed and incubated for 1 h at room temperature with
fluorescein isothiocyanate (FITC) anti-rabbit or tetramethyl rhodamine isothio-
cyanate (TRITC) anti-mouse secondary antibody (DakoCytomation), respec-
tively. Coverslips were mounted with a drop vector shield (Vector Laboratories,
Inc.), including DAPI (4,6-diamidino-2-phenylindole) (0.3 ng/l). Imaging of
the cells was done with 543-nm, 488-nm, and 405-nm excitation provided by an
argon laser and a 63  1.4-numerical-aperture Apochromat objective lens (Carl
Zeiss MicroImaging) for FITC, TRITC, and DAPI, respectively. Zeiss AIM
software, version 3.2, was used for merging the images.
Flow cytometry. To distinguish between live and dead cells, the DNA content
was determined. A total of 0.5  106 to 1.0  106 cells was fixed and perme-
abilized with ice-cold methanol (0.5 ml; 30 min), washed two times with PBS, and
incubated for 30 min with 0.5% (wt/vol) RNase A in PBS under constant shaking.
DNA was stained with propidium iodide (PI) (50 mg/ml in PBS), and fluores-
cence was measured by flow cytometry.
RNA isolation and cDNA synthesis. Total RNA was isolated using the Trizol
reagent (Life Technologies) as recommended in the manufacturer’s protocol.
Isolation of polysomal RNA by sucrose gradient fractionation was performed as
described previously (28, 36). Cell extracts were layered on a 4-ml linear sucrose
gradient (15 to 40% [wt/vol] sucrose), and eight fractions were collected. North-
ern blotting indicated that fractions 1 to 4 contain nonpolysomal and subpoly-
somal mRNA, and that fractions 5 to 8 consisted of polysome-bound RNA.
These fractions were pooled to generate subpolysomal and polysomal mRNA for
each sample. RNA was quantified by UV absorbance. Poly(A) mRNA was
purified, and cDNA was generated as described previously (28).
Real-time PCR. The real-time PCR assay involved TaqMan technology (PE
Applied Biosystems; model 7700 sequence detector) using the double-stranded-
DNA-specific fluorescence dye SYBR green I to detect PCR product as previ-
ously described (30). The amplification program consisted of 1 cycle of 50°C with
a 2-min hold (AmpErase UNG incubation) and 1 cycle of 95°C with a 10-min
hold (AmpliTaq Gold activation), followed by 40 cycles of denaturation at 95°C
for 15 s, annealing at 62°C for 30 s, and extension at 72°C for 30 s. All the
different primer pairs had similar optimal PCR annealing temperatures. Acqui-
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sition of the fluorescence signal from the samples was carried out at the end of
the elongation step. To confirm amplification specificity, the PCR products from
each primer pair were subjected to agarose gel electrophoresis, and the dissoci-
ation curve was checked at the end of each run. Gene-specific primers corre-
sponding to Ndpk-B (X68193), eukaryotic translation elongation factor eEF-12
(MGC:6763), eIF4E (M61731), Fli-1 (X59421), ornithine decarboxylase (ODC;
M12330), mammalian RNase inhibitor (IMAGE:1366946), U2 splicing factor
Snrpb (AA146248), and Y-box-binding protein 1 (YB-1; X57621) were obtained
from Invitrogen Life Technologies or Sigma-Genosys, Ltd. The sequences of the
primers used for the amplification are listed in Table 1.
RESULTS
Epo and SCF control eIF4E levels available for mRNA
translation. Since 4E-BP sequester eIF4E in the absence of
growth factors, we examined 4E-BP phosphorylation in ery-
throid progenitors in response to Epo and SCF. Upon factor
deprivation, only unphosphorylated 4E-BP are detected. Epo
induced partial phosphorylation of 4E-BP, while only SCF
induced complete phosphorylation of 4E-BP (Fig. 1A). A com-
parison of phosphospecific and total 4E-BP staining showed
that the migration of 4E-BP is directly related to its phosphor-
ylation state. An unphosphorylated 	-isoform, a partially phos-
phorylated -isoform, and a fully phosphorylated 
-isoform
can be discerned in agreement with the proposed two-step
phosphorylation mechanism (23). Importantly, SCF but not
Epo is able to induce phosphorylation of Ser64, the last step in
a cascade involving the sequential phosphorylation of T36/T45,
T69, and S64 to release eIF4E (Fig. 1B) (25). Epo/SCF-in-
duced phosphorylation of 4E-BP was abrogated in the pres-
ence of the PI3K inhibitor LY294002 and the mTOR inhibitor
rapamycin (Fig. 1B). The MEK1 inhibitor U0126 partially in-
hibited the hyperphosphorylation of 4E-BP (Fig. 1C), which
may indicate that part of the tuberous sclerosis complex/
mTOR pathway is controlled through MEK1 (37, 44). How-
ever, the major effect of LY294002 and the minor effect of
U0126 are in accordance with the observation that the inhibi-
tion of PI3K but not MEK1 abolished polysome association of
Ndpk-B (28).
Since only SCF induced full phosphorylation of 4E-BP dur-
ing a 10-min stimulation, we examined the kinetics of 4E-BP
phosphorylation to exclude the possibility that the difference
was due to different kinetics of induction and feedback mod-
ulation. Even after prolonged stimulation of erythroid progen-
itors with Epo, phosphorylation of 4E-BP was partial and only
small amounts of the fully phosphorylated 
-isoform were de-
tected. In contrast, SCF rapidly induced complete phosphory-
lation of 4E-BP, which was not dephosphorylated in the con-
tinuous presence of the factor (Fig. 1D). Subsequently, we
tested whether the phosphorylation of 4E-BP actually resulted
in reduced 4E-BP binding to eIF4E and increased association
of eIF4E with the scaffolding protein eIF4G. m7GTP-Sepha-
rose was used to precipitate eIF4E from an extract of 15  106
cells that were factor deprived or restimulated with Epo and/or
SCF. Surprisingly, the amount of 4E-BP pulled down from
restimulated cells increased, concomitant with increased pre-
cipitation of eIF4E. However, eIF4G binding to eIF4E also
increased (Fig. 1E). This indicates that 4E-BP is in excess but
that stimulation of erythroid progenitors with SCF does induce
eIF4F complexes.
The level of eIF4E available for mRNA translation initiation
is regulated by 4E-BP phosphorylation, but we also observed
factor-induced upregulation of eIF4E expression in mRNA
profiling experiments (30). Real-time quantitative PCR
showed that, following a 2-h Epo, SCF, or Epo/SCF exposure,
eIF4E mRNA increased approximately twofold in I/11 eryth-
roblasts compared to that in factor-deprived I/11 cells (Fig.
2A). This upregulation was due to an increase in total tran-
script because the relative distributions between subpolysome-
and polysome-associated mRNA did not change in response to
factor deprivation and restimulation (Fig. 2B). Increased
mRNA expression results in increased protein expression (Fig.
2C and D), which is in accordance with the data shown in Fig.
1E. During terminal erythroid differentiation, eIF4E mRNA
expression was downmodulated approximately fourfold in 72 h
(Fig. 2E).
Together, the data show that the level of eIF4E available for
mRNA translation is controlled by SCF on at least two levels:
phosphorylation of 4E-BP allowing increased eIF4G binding
and increased expression.
eIF4E overexpression in I/11 erythroid progenitor cells im-
pairs differentiation and enhances cell renewal. If regulation
of eIF4E is a major effector of SCF-induced PI3K, overexpres-
sion of eIF4E is expected to affect the PI3K-dependent balance
between the expansion and differentiation of erythroid progen-
itors (49). Using retroviral expression vectors, we established
multiple clones expressing myc-tagged eIF4E (eIF4E-myc)
(Fig. 3A). The eIF4E-myc could efficiently bind 4E-BP, which
enabled the exogenously expressed eIF4E-myc to titrate the
inhibitory function of 4E-BP (Fig. 3B). Using m7GTP-Sepha-
rose, we pulled down eIF4E from control and eIF4E-overex-
pressing cells that were factor deprived and restimulated. In
contrast to control cells, factor-deprived eIF4E-overexpressing
cells contained eIF4E-eIF4G complexes (Fig. 3C). More
eIF4G was recruited by eIF4E in the eIF4E-overexpressing
erythroid progenitors under all conditions (Fig. 3C and D).
Since all unphosphorylated 4E-BP was bound by the excess of
eIF4E, induction of 4E-BP phosphorylation upon stimulation
TABLE 1. Primer sequences used for real-time PCR amplification
Primer name Forward primer sequence Reverse primer sequence
Ndpk-B 5ATG GGA TTC GGA GAC CTG AA3 5TCA GCA GGT GGT GGA CCA GA3
eEF-12 5ATG GGA TTC GGA GAC CTG AA3 5TCA GCA GGT GGT GGA CCA GA3
eIF4E 5TCT AAT CAG GAG GTT GCT AAC3 5TAG ACA ACT GGA TAT GGT TGTA3
Fli-1 5TGC AGC CAC ATC CAA CAG AG3 5TGA AGG CAC GTG GGT GTT AG3
ODC 5TG ACG TCA TTG GTG TGA GC3 5TAT CAA GCA GAT GCA TGC TGT3
RI 5TCC AGT GTG AGC AGC TGA G3 5TGC AGG CAC TGA AGC ACC A3
U2 Snrpb 5TCA GTT TGG ACA CGT GGT AG3 5TCC TTG TCA GCG AAA GTA CCA3
YB-1 5TGC AGG AGA GCA AGG TAG AC3 5TGG TGG ATC GGC TGC TTT TG3
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of the cells with SCF resulted in a more pronounced decrease
in 4E-BP binding than that observed in control cells (compare
Fig. 1E and 3D). In conclusion, although the level of eIF4E-
myc overexpression detected in Fig. 3A is modest compared to
that of endogenous eIF4E, the increase in eIF4G association
indicates that the expression of eIF4E-myc significantly en-
hances the level of free eIF4E (not bound to 4E-BP).
Using immunofluorescence, we analyzed the subcellular lo-
calization of endogenous eIF4E and of eIF4E-myc. Previously,
it has been shown that eIF4E may accumulate in nuclear bod-
ies to prevent cytoplasmic translocation of specific mRNAs
(46). A small fraction of endogenous eIF4E appeared in nu-
clear bodies, but eIF4E-myc appeared to be exclusively cyto-
plasmic (Fig. 3E). Thus, it is not likely that eIF4E-myc in
erythroid progenitors functions through a nontranslational
mechanism such as retaining specific mRNAs in the nucleus.
Finally, we also expressed an eIF4E mutant in which trypto-
phan-73 was mutated to alanine (W73A mutant) in I/11 cells.
The W73A mutant is unable to bind the scaffolding protein
eIF4G or 4E-BP. A low level of eIF4E(W73A) expression was
detected in mass cultures within a week after transduction, but
expression of this mutant was rapidly lost and we were unable
to establish single-cell-derived clones expressing the W73A
mutant (data not shown). This suggests that positive factors
can also be competed for by eIF4E-myc overexpression.
To examine the effect of eIF4E overexpression on the bal-
ance between the expansion and differentiation of erythroid
progenitors, we exposed vector control cells and eIF4E-myc-
expressing clones to conditions inducing expansion (Epo, SCF,
and Dex), delayed differentiation (Epo and SCF), differentia-
tion (Epo), or apoptosis (no factor). Both control and eIF4E-
myc-expressing cells failed to proliferate or mature in the ab-
sence of growth factors (Fig. 4A and E). Under differentiation
conditions, i.e., in the presence of Epo only, control cells un-
dergo prompt differentiation, characterized by transient pro-
liferation, decreased cell size, and the accumulation of hemo-
globin (Fig. 4A to C). Notably, this differentiation is markedly
delayed in eIF4E-myc-expressing cells, which is indicated by
prolonged expansion, maintenance of a blast-like cell size, and
lack of hemoglobin accumulation (Fig. 4E to G). In the pres-
ence of Epo plus SCF, control cells were delayed in differen-
tiation, but cell size reduction started almost as rapidly as in
the presence of Epo only. Under these conditions, differenti-
ation of eIF4E-myc-expressing cells was essentially absent. The
delay of differentiation in eIF4E-myc-expressing cells is also
evident from the cell morphology of the distinct cultures after
4 days of exposure to Epo (Fig. 4D and H). The effect of
eIF4E-myc expression on Epo-dependent differentiation was
analyzed for multiple independent clones, which showed con-
sistent inhibition of differentiation (Fig. 5).
Measuring the DNA content by flow cytometry at day 3
following reseeding in differentiation medium confirmed that
control cells arrest in the G1 phase of the cell cycle, while
eIF4E-myc cells can be detected in all phases of the cell cycle
(Fig. 6A; the G1 peak of control cells is shifted to the left
because the highly condensed DNA of late erythroblasts binds
less propidium iodine; no significant number of apoptotic cells
is detected by annexin staining or the terminal deoxynucleoti-
dyltransferase-mediated dUTP-biotin nick end labeling assay).
However, eIF4E-myc-expressing cells are not transformed and
FIG. 1. Phosphorylation of 4E-BP is controlled by SCF and Epo in
erythroid progenitors. (A and B) I/11 cells were factor deprived for 4 h,
stimulated with Epo (lane E; 5 U/ml), SCF (lane S; 100 ng/ml), or Epo
plus SCF (lane ES) for 10 min, or left untreated (lane NF). (C) I/11
cells were factor deprived in the presence of 10 M LY294002 (lane
LY), 10 nM rapamycin (lane R), or 20 M U0126 (lane U) and
stimulated for 10 min with Epo and SCF (ES) in the presence of the
inhibitors. Minus lanes indicate no inhibitor added. Western blots with
total cell lysates (A and C) or with 4E-BP immunoprecipitates
(B) were stained with antibodies recognizing T36/T45-phosphorylated
4E-BP (	-P[T36/T45]-4E-BP), S64-phosphorylated 4E-BP (	-P[S64]-
4E-BP), or total 4E-BP (	-4E-BP). ERK 1/2 staining was used as a
sample loading control (	-ERK1/2). The unphosphorylated 	-isoform,
a partially phosphorylated -isoform, and a fully phosphorylated 
-iso-
form of 4E-BP are indicated in panel A. (D) Samples were taken at
various time points (0, 10, 30, 60, 120, and 180 lanes) following the
addition of Epo or SCF (lane ss, steady state; cells not subjected to
factor deprivation). Western blots were stained with antibodies recog-
nizing 4E-BP. (E) I/11 cells were factor deprived (lane NF) or restim-
ulated (lanes E and S) as indicated in panels A and B, and eIF4E was
precipitated with m7GTP-Sepharose. Precipitates were stained for
eIF4G, 4E-BP, and eIF4E on Western blots.
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fail to undergo prolonged renewal in the presence of Epo.
Seven days following reseeding in differentiation conditions,
the cultures of eIF4E-myc-expressing cells accumulate cells
with a sub-G1 DNA content and annexin-positive staining (Fig.
6B and data not shown), suggesting increased apoptosis. In the
control cultures, all cells enucleated. These results were con-
firmed in four control clones and six eIF4E-myc-expressing
clones. The failure to undergo differentiation could be due to
the failure to downregulate eIF4E (Fig. 2C). Indeed, expres-
sion of eIF4E protein decreased during the differentiation of
control cells, followed by decreased expression of 4E-BP. How-
ever, expression of endogenous eIF4E remained high in
eIF4E-myc progenitors (Fig. 6C).
PI3K inhibition does not abrogate cell expansion of eIF4E-
overexpressing I/11 cells. We showed that PI3K activity rather
than MEK1/extracellular signal-regulated kinase (ERK) acti-
vation is essential to maintain cell renewal divisions in ery-
throid progenitors (49). Since the phosphorylation of 4E-BP
and the release of eIF4E is downstream of PI3K, we analyzed
whether constitutive expression of eIF4E maintains cell re-
newal in the presence of the PI3K-inhibitor LY294002. The
addition of LY294002 to renewal conditions decreased the
expansion of control cultures and accelerated cell differentia-
tion evidenced by increased hemoglobinization. In contrast,
eIF4E-myc-expressing cells did not alter cellular renewal or
differentiation in response to LY294002 (Fig. 7). This indicates
that control of translation initiation is a major target of PI3K
in erythroid development.
Polysome association of Ndpk-B, U2-Snrpb, and YB-1 tran-
scripts depends on PI3K activation or eIF4E expression. Re-
cently we screened for Epo- and SCF-induced genes in a pro-
filing assay using polysome-bound mRNA. The expression of
Ndpk-B appeared to be controlled specifically at the level of
polysome recruitment by a mechanism involving SCF-activated
PI3K activity (28). Since other targets upregulated by SCF may
be regulated by the same mechanism, the expression of Epo-
and SCF-upregulated genes was examined by quantitative re-
verse transcription-PCR in total, free, and polysome-associ-
ated mRNA fractions (data not shown). In addition to Ndpk-B,
we found expression of the splicing factor U2-Snrpb and the
Y-box-binding protein 1 (YB-1) to be regulated by polysome
association (data not shown and Fig. 8). In the absence of
growth factor, less than 10, 5, and 25% of Ndpk-B, YB-1, and
U2-Snrpb mRNAs, respectively, were detected in the polyso-
mal fractions. Upon stimulation with Epo and SCF, 75% of the
FIG. 2. eIF4E expression is upregulated upon growth factor stim-
ulation in I/11 cells. (A and B) I/11 cells were factor deprived for 4 h
and stimulated with Epo (E), SCF (S), or Epo plus SCF (ES) or left
untreated (NF) for 2 h. Total (A) and free and polysome-associated
mRNA (B) was isolated, and eIF4E mRNA was quantified using
real-time PCR. (A) eIF4E expression is given as a change (n-fold) ratio
of that in factor-stimulated cells to that in untreated cells. (B) The
percentage of eIF4E mRNA present in the polysome-bound (pb) frac-
tion is calculated. (C) I/11 cells were factor deprived and restimulated
with Epo plus SCF for various time intervals (0, 10, 30, 60, and 120
lanes) as indicated. Protein samples were analyzed on Western blots
for eIF4E expression. The Western blots were stained with 	-actin to
control for equal loadings. ss, steady state. (D) Quantification of eIF4E
intensities. Bars indicate the averages from three independent exper-
iments, a representative of which is shown in 2C. Error bars indicate
standard deviations. ss, steady state. The insert demonstrates the lin-
earity of the eIF4E antibody used (R2  0.9988). Twofold dilutions of
total cell lysate were tested for eIF4E expression. Expression is given
in arbitrary units (a.u.). (E) I/11 cells were induced to differentiate, and
samples were harvested for mRNA isolation at the indicated time
points. Expression of eIF-4E was examined by real-time RT-PCR and
is given as a change (n-fold) ratio of eIF-4E expression to expression
in expanding I/11 cells (time zero).
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Ndpk-B, 80% of the U2-Snrpb, and 50% of the YB-1 messen-
gers were found in the polysomal fractions, and polysome
association was dependent on PI3K activation (Fig. 8A to C).
Whereas the 5UTR of Ndpk-B starts with a TOP tract and
contains an inverted repeat, the 5UTR of U2-Snrpb is short
and contains a TOP sequence (AA146248), and the 5UTR of
YB-1 is long and highly structured and lacks a TOP sequence
(21) (X57621). Thus, these three genes represent different
types of mRNAs and may be representative panels to study the
pathways involved in gene-specific mRNA recruitment to poly-
somes. We examined the effect of eIF4E overexpression on
factor-dependent polysome association of Ndpk-B, U2-Snrpb,
and YB-1 mRNA. Polysome recruitment of Fli-1 mRNA was
analyzed as a negative control to assess the general effect of
LY294002 and rapamycin on polysome formation. Polysome
association of eukaryote elongation factor 1 (eEF1) and
ODC was examined as a positive control. They contain a TOP
sequence and a highly structured 5UTR, respectively. En-
FIG. 3. Ectopic eIF4E-myc protein is able to interact and titrate out endogenous 4E-BP and is localized mainly in the cytoplasm of I/11 cells.
(A) Lysates of an empty-vector-transduced clone (eV lane) and various eIF4E-myc-transduced clones (eIF4E overexpressor lanes) were tested for
eIF4E expression on Western blots using antibodies recognizing eIF4E (top panel) or the myc-tagged protein (bottom panel). The eIF4E-myc and
endogenous eIF4E proteins have different mobilities and are indicated by arrows. (B) myc-eIF4E-expressing I/11 cells expanding in the presence
of Epo, SCF, and Dex (steady state [ss] lanes) or factor deprived for 4 h (NF lanes) were lysed, and eIF4E-myc was immunoprecipitated with
anti-Myc antibody (	-myc,  lanes). Mock immunoprecipitations using Sepharose beads without antibody ( lanes) served as controls. Western
blots were stained for 4E-BP (top) or the myc-tagged protein (bottom). Unphosphorylated and hypophosphorylated 4E-BP (	- and -forms) were
coimmunoprecipitated with eIF4E-myc. The myc-tagged eIF4E could efficiently bind to endogenous 4E-BP. (C and D) eIF4E was precipitated by
m7GTP-Sepharose and tested for eIF4G and 4E-BP association on Western blots. Endogenous eIF4E was detected by specific antibody, and
eIF4E-myc was detected by anti-Myc antibody. Lysates were prepared from eIF4E-myc-expressing and control I/11 cells that were steady-state
expanding (lanes ss) or factor deprived (lanes NF) (C) or factor deprived and restimulated with Epo (lanes E; 5 U/ml, 60 min), SCF (lanes S; 100
ng/ml; 60 min), or Epo plus SCF (lanes ES) (D). (E) Cytospins of empty vector (upper left panel) and eIF4E-myc (middle and lower left panels)
expressing I/11 cells are fixed and stained for eIF4E (upper and middle left panels) or the myc-tagged protein (lower left panel) using FITC- and
TRITC-labeled second antibodies, respectively. In addition, nuclei of all cells are stained with DAPI (middle panels). The right panels represent
the overlay of eIF4E or myc-tagged protein with DAPI. A small fraction of endogenous eIF4E appeared in nuclear bodies, whereas eIF4E-myc
seemed to be exclusively cytoplasmic.
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hanced eIF4E expression increased polysome association of
Ndpk-B, YB-1, and U2-Snrpb mRNA in factor-deprived cells,
and it rendered factor-induced polysome association resistant
to the PI3K inhibitor LY294002 (Fig. 8). The polysome asso-
ciation of the mRNAs in Epo- or SCF-stimulated cells was the
same for control and eIF4E-overexpressing cells.
Both control mRNAs, eEF1 and ODC, known to be regu-
lated by polysome association, showed the same levels of reg-
ulation as Ndpk-B, YB-1, and U2-Snrpb. In contrast, at least
half of all Fli-1 mRNA remained associated with polysomes
independently of PI3K activity. Upon factor deprivation and
inhibition of PI3K, 20 to 25% of the Fli-1 mRNA was lost from
polysomes. This can be considered the general effect of growth
factor stimulation on mRNA translation initiation, which is
much lower than the effect observed for structured mRNAs.
DISCUSSION
Control of the expansion versus maturation of hematopoi-
etic progenitors requires a tight regulation of the gene expres-
sion program. It becomes increasingly evident that the expres-
sion of genes critical for progenitor renewal and tumorigenesis
is regulated not only at the level of gene transcription, but also
by control of mRNA translation (14). The expansion of ery-
throid progenitors is critically dependent on SCF-induced
PI3K activity. SCF-induced PI3K/PKB activity controls the
level of eIF4E available for translation initiation, and we
showed that overexpression of eIF4E in erythroid progenitors
impairs their differentiation and enhances renewal divisions in
the absence of SCF. Notably, the inhibition of PI3K did not
lead to the differentiation of eIF4E-overexpressing erythroid
progenitors as it does in control cells, indicating that control of
eIF4E is a pathway of major importance downstream of PI3K
FIG. 4. Overexpression of eIF4E impairs differentiation of I/11 erythroid progenitors. I/11 cells transduced with an empty control vector (A to
D) or with an eIF4E expression vector (E to H) were seeded in medium without factor () or supplemented with Epo (E; 2 U/ml), Epo plus SCF
(ES; 100 ng/ml SCF), or Epo, SCF, and dexamethasone (ESD; 106M dexamethasone). (A and E) Cumulative cell number, (B and F) cell size,
and (C and G) hemoglobin content per cell volume (arbitrary units [a.u.]) were analyzed at regular intervals for 7 days. At day 4, cells seeded in
Epo were harvested for cytospins and stained for hemoglobin (brown) and histological dyes (D and H). Hemoglobinized and enucleated
erythrocytes were present in control cells, while eIF4E-expressing cells contain mainly blasts.
FIG. 5. Overexpression of eIF4E consistently impairs differentia-
tion of I/11 erythroid progenitors. (A and B) Vector and eIF4E-myc-
transduced clones were subjected to differentiation as described for
Fig. 4. The average cell volume (A) and hemoglobin content (B), as
measured 3 and 4 days following induction of differentiation, are
shown for six clones. Error bars represent standard deviations.
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in expanding erythroid progenitors. We observed that either
SCF-induced signal transduction or eIF4E overexpression re-
sulted in a significant increase in the polysome recruitment of
a specific set of mRNAs with a structured 5UTR, such as
Ndpk-B, YB-1, and U2-Snrpb. This supports the notion that
the expression of not only ribosomal proteins and translation
factors but also other proteins with an important role in cel-
lular metabolism and proliferation is controlled at the level of
polysome recruitment. Therefore, we suggest that gene-spe-
cific recruitment of mRNAs into polysomes by SCF-induced
PI3K/PKB activity may contribute to the control of expansion
and maturation of erythroid progenitors.
Release of eIF4E is a major pathway downstream of PI3K in
erythroid progenitors. Overexpression of eIF4E specifically
inhibits differentiation. Notably, the induction of erythroid
maturation does not require the inhibition of cell cycle pro-
gression but involves three to four cell divisions with loss of cell
size control, resulting in 8 to 16 erythrocytes (4 m, in mice)
from a single proerythroblast (12 m) (16, 49). In conse-
quence, maintenance of cell size is crucial in renewal divisions,
which requires a proper balance between protein synthesis and
G1 progression through the restriction point in the cell cycle
(17, 50). This indicates an important role for protein synthesis
and for a limiting factor in mRNA translation, such as eIF4E
in particular, in the control of the expansion and differentiation
of erythroid progenitors.
We previously showed that inhibition of PI3K abrogates the
ability of erythroid progenitors to maintain a renewal program
(49). Because overexpression of eIF4E rendered the expansion
of erythroid progenitors insensitive to the PI3K inhibitor
LY294002, selective protein synthesis appears to be a major
pathway downstream of SCF-induced progenitor expansion.
However, we also demonstrated that SCF-induced activation
of the PI3K/PKB pathway results in the phosphorylation of
Foxo3, which results in its cytoplasmic retention and inhibition
of its transcriptional activity (5). Among the Foxo3 targets are
p27, p130Rb2, Btg1, and cyclin G2, which all inhibit cell cycle
progression (5; W. J. Bakker, submitted for publication). These
genes are upregulated when PI3K activity is inhibited in con-
trol cells. Yet, erythroid progenitors overexpressing eIF4E un-
dergo normal renewal divisions in the absence of PI3K activity.
This seeming contradiction may have two explanations. First,
the expression of Foxo family members is low in erythroid
progenitors, and Foxo3 expression is markedly increased dur-
FIG. 6. eIF4E overexpression in I/11 cells impairs differentiation
but fails to prolong renewal in the presence of Epo. (A and B) Empty
vector (EV) control clones and eIF4E-myc-expressing cells (eIF4E)
were fixed and permeabilized, stained with PI, and analyzed by flow
cytometry. (A) Three days following reseeding of the cells in differen-
tiation medium (supplemented with Epo only), the EV control cells
were predominantly arrested in the G1 phase of the cell cycle, and the
G2 peak was absent. The level of PI staining is relatively low because
the nuclei are condensed and bind less PI. A prominent peak repre-
senting the G2 phase of the cell cycle is present in eIF4E-overexpress-
ing cells. (B) At day 6 and day 7 following seeding in differentiation
medium, the eIF4E-overexpressing cells were still in cycle as demon-
strated by the G2 peak, but in time, the number of cells with a sub-G1
DNA content (indicating dead cells) accumulates. (C) Protein lysates
of empty vector (EV lanes) control clones and eIF4E-myc-expressing
cells (eIF4E lanes) were harvested at increasing intervals following the
reseeding of the cells in differentiation medium. Western blots were
stained with antibodies recognizing endogenous eIF4E, 4E-BP, or
ERK 1/2 as indicated. Erk served as a loading control.
FIG. 7. Overexpression of eIF4E renders cells insensitive to the
PI3K inhibitor LY294002. Two empty-vector control clones and two
eIF4E-overexpressing clones (black and white symbols indicate sepa-
rate clones) were seeded in medium supplemented with Epo and SCF
(ES) in the absence (diamonds) or presence (circles) of LY294002
(LY; 10 M). (A) Total cell number and (B) hemoglobin (Hb) content
per cell volume (in arbitrary units [a.u.]) were monitored daily.
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ing differentiation, resulting in Foxo3 activity 48 h after induc-
tion of differentiation when cells arrest in G1. The low levels of
Foxo3 protein in erythroid progenitors may result in insuffi-
cient expression of the cell cycle inhibitors to arrest cells when
all other signals are activated. Second, preliminary analysis of
translationally controlled genes suggests that increased eIF4E
expression results in the enhanced expression of proteins that
inhibit the cell cycle inhibitors such as kinase interacting with
stathmin (KIS) (unpublished data). Thus, control of eIF4E
availability is a major pathway downstream of PI3K to main-
tain renewal divisions of erythroid progenitors. Upon down-
regulation of PI3K, other pathways, such as Foxo3 activation,
are activated to execute the differentiation program.
Constitutive eIF4E expression does not render erythroid
progenitors independent of growth factors. It has been shown
that the PI3K/PKB/mTOR pathway is required for the tumor-
igenic phenotype of various tumors and sufficient for onco-
genic transformation of chicken embryo fibroblasts (2, 3, 15).
In breast tumor-derived cell lines and eIF4E-transformed fi-
broblasts, increased expression of eIF4E and phosphorylation
of 4E-BP prevent apoptosis upon factor deprivation. Erythroid
progenitors overexpressing eIF4E are not factor independent
for either renewal or differentiation and are not prevented
from apoptosis in the absence of growth factors. Moreover,
eIF4E expression impairs differentiation but is not able to
sustain long-term renewal. Upon moderate overexpression, the
FIG. 8. eIF4E overexpression increases polysome association of structured mRNAs in the absence of growth factors or in the presence of
growth factors and the PI3K inhibitor LY294002. I/11 control cells (filled bars) and eIF4E-overexpressing cells (open bars) were factor deprived
in the absence or presence of LY294002 (LY; 10 M) or rapamycin (R; 10 nM) and restimulated for 2 h with Epo (E; 5 U/ml), SCF (S; 100 ng/ml),
or Epo plus SCF (ES). In addition, cells were left untreated (NF) or were harvested from steady-state proliferating cultures (ss). Free and
polysome-bound mRNA was isolated and assayed for the expression of (A) NdpkB, (B) YB-1, (C) U2-Snrpb, (D) eIF12, (E) ODC, and (F) Fli-1.
The percentage of mRNA associated with polysomes (pb mRNA) was calculated for the different genes under the different conditions.
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cells undergo delayed differentiation, but high levels of eIF4E
eventually induce erythroid progenitors to die under differen-
tiation conditions. Whereas eIF4E availability may be the cru-
cial pathway downstream of PI3K signaling, it is not sufficient
for sustained expansion or differentiation of erythroid progen-
itors. The distinct effects of eIF4E overexpression in different
cell types, i.e., control of apoptosis versus control of differen-
tiation, is in accordance with the different functions of PI3K
and Foxo transcription factors in these cells. Whereas PI3K is
known mainly as a survival factor in fibroblastoid cells (20), it
controls the balance between the expansion and differentiation
of erythroid progenitors (5, 47). The tyrosine kinase receptor
RON/Stk is a downstream target of the EpoR (47). Direct
activation of RON, using a NGF-inducible TrkA-RON fusion,
induced phosphorylation of Gab1 and Gab2 and strong PI3K
activation, but it was not able to induce renewal divisions in the
absence of SCF or differentiation in the absence of Epo. Thus,
expansion requires additional signaling pathways initiated by
the SCF receptor cKit, and differentiation requires Epo-in-
duced Stat5 activation (18, 47). Whether the biological effect of
eIF4E is the rescue from apoptosis or impaired differentiation,
in either case, it contributes to enhanced expansion of progen-
itors and to neoplastic transformation.
Increased eIF4E expression recruits specific RNA tran-
scripts to polysomes. Although eIF4E is predominantly a
translation initiation factor, overexpression of eIF4E in my-
eloid progenitors was suggested to contribute to leukemogen-
esis by increased nuclear export of cyclin D1 (46). The proline-
rich homeodomain protein, PRH/Hex, disrupts eIF4E nuclear
bodies and reduces export of D-cyclins (46). We did observe
nuclear bodies in control cells using antibodies against endog-
enous eIF4E, but upon overexpression of eIF4E, these nuclear
bodies disappeared. Interestingly, we found that PRH/Hex is
upregulated in response to SCF. This involved both transcrip-
tional and translational control, as the 28-bp-long 5UTR of
the PRH transcript contains a TOP sequence (G. Grech, un-
published results). Possibly, the increased expression of PRH/
Hex suppressed the nuclear localization of eIF4E.
In consequence, the delayed differentiation of erythroid pro-
genitors upon overexpression of eIF4E must be due to the
effects of eIF4E on mRNA translation. Increased availability
of eIF4E allows more eIF4F, harboring the eIF4A helicase, to
bind and scan structured mRNAs, i.e., to recruit the structured
mRNAs into polysomes (24). Until recently, PI3K/PKB/
mTOR-dependent polysome recruitment was described mainly
for mRNAs containing a TOP sequence and encoding ribo-
somal proteins and translation factors (34, 43). Few other
structured mRNAs were shown to be regulated at the level of
translation initiation like c-Myc and ODC (14). In this paper,
we describe PI3K- and eIF4E-dependent polysome recruit-
ment of Ndpk-B, YB-1, and U2-Snrpb. Notably, both Ndpk-B
and YB-1 are suggested to be involved in tumor progression
(26, 38). The Ndpk-B 5UTR contains a TOP tract and an
inverted repeat predicted to form a stem-loop structure (28).
Removal of the Ndpk-B 5UTR caused the loss of Ndpk-B
translational control. YB-1 mRNA contains a highly structured
5UTR and lacks a TOP tract, whereas U2-Snrpb has a short
5UTR starting with a TOP sequence. All three mRNAs as
well as the controls EF1 (TOP mRNA) and ODC (structured
mRNA) were hardly or not associated with polysomes in the
absence of growth factors. Of unstructured mRNAs, such as
Fli-1 mRNA, at least 50% of the mRNA remains associated
with polysomes in the absence of growth factors. Overexpres-
sion of eIF4E increased polysome association of Ndpk-B, YB-1,
and U2-Snrpb in the absence of growth factors but did not
completely rescue polysome association relative to SCF-in-
duced polysome association. This suggests that additional sig-
naling still plays a role in mRNA translation, possibly by the
phosphorylation of proteins that stabilize structures in the mR-
NAs.
Besides increased recruitment of structured mRNAs to poly-
somes, increased expression of eIF4E may act via other mech-
anisms as well, and such additional mechanisms may contrib-
ute to the observed phenotype of eIF4E-overexpressing
erythroid progenitors. In conjunction with other initiation fac-
tors (eIF2 and eIF3), eIF4E affects the selection of the ATG
initiation codon. Under conditions of suboptimal growth fac-
tors, protein synthesis will start at the first ATG start codon
that is embedded in an optimal Kozak sequence (32). When
translation initiation factors are abundantly available, less-op-
timal ATG codons can be selected to start protein synthesis,
and eIF4F will continue mRNA scanning beyond a first open
reading frame (ORF) to reinitiate at the next ATG. Short
ORFs in the 5UTR can serve to attenuate translation of the
functional ORF (e.g., thrombopoietin) (22), but upstream
ORFs can also affect the choice of the start codon for the
functional protein and thereby the translation of antagonistic
proteins from the same mRNA (e.g., CEBP and SCL) (11,
12).
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